Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
about
The effectiveness of using interferon-gamma release assays in screening immigration employees for latent tuberculosis infectionMortality hazard and survival after tuberculosis treatmentScreening of healthcare workers for tuberculosis: development and validation of a new health economic model to inform practiceDifferent screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysisRevisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.Priorities for screening and treatment of latent tuberculosis infection in the United StatesSystematic review of cost and cost-effectiveness of different TB-screening strategies.Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis.Pairing QuantiFERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the Southeastern United StatesCurrent approaches to tuberculosis in the United States.Recent advances in testing for latent TB.QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis.How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBICost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of GeorgiaCost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.Multicytokine detection improves latent tuberculosis diagnosis in health care workersCost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.Is it time to replace the tuberculin skin test with a blood test?Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in childrenEvaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers.Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States.TB diagnostic tests: how do we figure out their costs?IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults.Performance of QuantiFERON-TB Gold and tuberculin skin test relative to subjects' risk of exposure to tuberculosis.Transmission and Institutional Infection Control of Tuberculosis.Tuberculosis screening of new hospital employees: compliance, clearance to work time, and cost using tuberculin skin test and interferon-gamma release assays.The effectiveness of screening with interferon-gamma release assays in a university health care setting with a diverse global population.Cost-effectiveness of using Quantiferon Gold (QFT-G)® versus tuberculin skin test (TST) among U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis.Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-α antagonist therapy.Prophylaxis for latent tuberculosis infection prior to anti–tumor necrosis factor therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis.Updating a tuberculosis surveillance program: considering all of the variables.Carbohydrate antigen 125 and carcinoembryonic antigen in the differentiation of tuberculous peritonitis and peritonitis carcinomatosa.Cost-effectiveness of interferon-gamma release assay for entry tuberculosis screening in prisons.Cost-effectiveness analysis of interventions for tuberculosis control: DALYs versus QALYs.Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers.Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons
P2860
Q24170493-9C381C90-DE69-4EF3-AC3A-5D360A798F70Q28391275-79124FB7-669D-4BEA-89C2-A76083D38F4CQ28731558-F9067E7F-DBA7-408D-816D-D8ABDEAC582AQ33532816-A1185518-42B7-41FA-9942-688FAA3E1F7CQ33702764-3CF26124-22D0-4D81-B1CF-25D7623CB7C6Q33895875-C576FC64-3FCF-49E5-90D0-E34D4C853516Q34036168-743C4809-AE47-48A2-A573-1C3FDC2DABDCQ34046364-B25C2855-EDE2-4926-985C-181B528EF49FQ34218697-A84D0680-8D0B-475B-B017-CDF9FC584A49Q34279727-8B45DAF3-C85E-4F2D-A130-D1D331C9A725Q34386405-2798C4C3-7CE4-4CDC-A536-94D21900F31CQ34518338-A50739FB-07D2-4832-BA08-3BC248542881Q34625452-FF2D33ED-F1D7-4061-8901-78B5160CD3C4Q34672436-FB53FF4B-3F83-411C-A88C-DA464DFC355DQ35029529-05B2A94B-28F4-49BB-8777-0BF18315BF1EQ35577840-24F42540-1B4F-4D76-9768-E7AF7052E513Q35943027-B8790073-FA33-461B-B86E-09C749B9111DQ36161757-21D5F8D2-6DC1-4D42-A20C-0B8E1DF1CFE1Q36239684-48332D8C-4BF4-41C9-B96F-19FB351B580FQ37308287-825C1D88-416A-4761-B32E-A80356411BB0Q37465712-990EF951-B612-4678-ACE9-99DFE1FABD21Q37478715-FF5F221C-FBB9-402E-84B0-41D694B491F1Q37579924-97AB1ED5-D2C2-420D-BE3D-C840950963DDQ38069419-1DA7B3E7-F169-4344-A8D5-33E48E421EC2Q38192554-01726DF8-0E29-4B3F-BCC9-2A61B2F7DA89Q38570423-AF19A012-F2CD-47BA-A328-4777FCF955F8Q40221251-85B0B332-3166-4F0C-B6C7-E18BEB11AAC2Q41593849-EEFA609F-9998-4D5F-BD65-06F7EE90014EQ43652113-6FC85BB4-313A-4ECD-AB49-FAFF4F3EAEF7Q44051009-42449AD4-C95C-46C9-A2E5-B64ED89253FDQ44381410-AB66AC3C-8863-469B-A34A-388AAD452479Q44977071-7A81EA52-DFA8-42BA-81EB-5A256D391AEAQ45350715-0A0E5BF0-E8AE-4E57-AF5F-98AC5C1385F5Q45391637-76C4015F-68F4-41C1-B175-77CEFB39434FQ50682458-C575F2AA-CE6A-49CA-89BF-8C95D325836EQ50897549-C5A40A78-8E97-4197-A86B-B2870395A3EBQ51153954-9937023E-CE9C-446A-9BF6-721F41F3C5A0Q55016083-679FB11B-D9C4-4346-8B8D-F2C6A76D8736Q58586061-CFC7D18D-4469-40E6-BE87-DB1BECF1C38C
P2860
Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Cost-effectiveness of interfer ...... tests in health care workers.
@en
type
label
Cost-effectiveness of interfer ...... tests in health care workers.
@en
prefLabel
Cost-effectiveness of interfer ...... tests in health care workers.
@en
P2093
P1476
Cost-effectiveness of interfer ...... n tests in health care workers
@en
P2093
Gary A Roselle
Joel Tsevat
Marie A de Perio
Stephen M Kralovic
P304
P356
10.1001/ARCHINTERNMED.2008.524
P407
P577
2009-01-01T00:00:00Z